We are the front-runner in the field of ARS(Aminoacyl-tRNA Synthetase)-based therapeutics, developing first-in-class anti-tumorigenic peptide drugs. Our 3 defined pipelines, all based on our own research on human proteins, are now on trial at high speed targeting 3 indications - renal cell carcinoma, ovarian cancer and androgenic alopecia.
For speaking, sponsorship and exhibition opportunities contact
jonathan.mottram@terrapinn.com
Tel: +65 6322 2738